Corrigendum to 'Alantolactone inhibits proliferation, metastasis and promotes apoptosis of human osteosarcoma cells by suppressing Wnt/β-catenin and MAPKs signaling pathways' [Genes & Diseases 9 (2022) 466-478]
CORRIGENDA
Corrigendum to 'Alantolactone inhibits proliferation, metastasis and promotes apoptosis of human osteosarcoma cells by suppressing Wnt/β-catenin and MAPKs signaling pathways' [Genes & Diseases 9 (2022) 466-478]
124200
The authors regret.
In the MG63 panels, the 0 mm photo has been replaced.
